Taken together, the results above suggest that PARP1 could induce cardiac hypertrophy and positively regulate C/EBPβ protein level without affecting its transcription level, which imply C/EBPβ may participate in PARP1-induced cardiac hypertrophy. The gene discussed is PARP1; the disease is cardiac hypertrophy.